PRESS RELEASE CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary…
Acacia Pharma Group PLC THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART,…
NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that…
NEW YORK and VIENNA, Austria, June 09, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing…
Groundbreaking technology introduces increased control to achieve optimal coverage proven to significantly reduce the risk of toxicity to the rectumSANTA…
STAMFORD, Conn., June 09, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing…
DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the…
RESEARCH TRIANGLE PARK, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered…
Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General HospitalCHATHAM, N.J., June 09, 2022 (GLOBE NEWSWIRE) --…
Management Pursues Growth By Bringing Advanced Wellness Through Advantageous Senior Pricing LAS VEGAS, NV, June 09, 2022 (GLOBE NEWSWIRE) --…